Author:
Hooten Joanna N.,Myers Sarah A.
Publisher
Springer International Publishing
Reference195 articles.
1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2011 Annual Data Report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2012. [11/5/2013]. Available from: http://srtr.transplant.hrsa.gov/annual_reports/2011/ .
2. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol. 1992;10:333–58. PubMed PMID: 1590990. Epub 1992/01/01. eng.
3. Beiras-Fernandez A, Thein E, Hammer C. Induction of immunosuppression with polyclonal antithymocyte globulins: an overview. Exp Clin Transplant. 2003;1(2):79–84. PubMed PMID: 15859913. Epub 2005/04/30. eng.
4. Mottershead M, Neuberger J. Daclizumab. Expert Opin Biol Ther. 2007;7(10):1583–96. PubMed PMID: 17916050. Epub 2007/10/06. eng.
5. Ramirez CB, Marino IR. The role of basiliximab induction therapy in organ transplantation. Expert Opin Biol Ther. 2007;7(1):137–48. PubMed PMID: 17150025. Epub 2006/12/08. eng.